Richard A Smith

Title: Richard A Smith: A Pioneer in Complement Research

Introduction

Richard A Smith, an innovative inventor based in Relgate, Surrey, GB, has made significant contributions to the field of biomedical research with three patents to his name. His work primarily focuses on the therapeutic applications of glycoforms in preventing and treating various medical conditions.

Latest Patents

Smith's latest patents revolve around the preparation and use of sialylated glycoforms of soluble complement. One of his notable inventions includes methods for creating preparations of recombinant soluble Complement Receptor type 1 (sCR1) defined by the distribution of sCR1 glycoforms. These preparations hold promising potential for treating allograft or xenograft rejection, diseases involving inflammation or inappropriate complement activation, and conditions like thrombotic or shock states. The methods prefer the use of sCR1 glycoforms that are sialylated, possess a pI of ≤ 5.1, or have a sialic acid:mannose molar ratio of ≥ 0.25.

Career Highlights

Throughout his career, Richard A Smith has worked with leading organizations such as T Cell Sciences, Inc. and SmithKline Beecham Corporation. His expertise and dedication to the field have allowed him to establish himself as a valuable inventor and researcher in the realm of biomedical innovations.

Collaborations

Smith has collaborated with renowned colleagues in the industry, including Henry C Marsh and Chang-Jing Grace Yeh. These partnerships have enhanced his research and contributed to the development of innovative therapeutic methods in the field of complement research.

Conclusion

Richard A Smith is a distinguished inventor whose work continues to push the boundaries of biomedical research. His patents highlight the significance of sialylated glycoforms in treating complex medical conditions, paving the way for future innovations in the field.